{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:59:26Z","timestamp":1789639166114,"version":"4.0.0"},"reference-count":52,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009687","name":"Wroclaw Medical University","doi-asserted-by":"publisher","award":["SUBZ.D130.23.001"],"award-info":[{"award-number":["SUBZ.D130.23.001"]}],"id":[{"id":"10.13039\/501100009687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Colorectal cancers are one of the leading cancers worldwide and are known for their high potential for metastasis and resistance to therapy. The aim of this study was to investigate the effect of various combination therapies of irinotecan with melatonin, wogonin, and celastrol on drug-sensitive colon cancer cells (LOVO cell line) and doxorubicin-resistant colon cancer stem-like cells (LOVO\/DX cell subline). Melatonin is a hormone synthesized in the pineal gland and is responsible for circadian rhythm. Wogonin and celastrol are natural compounds previously used in traditional Chinese medicine. Selected substances have immunomodulatory properties and anti-cancer potential. First, MTT and flow cytometric annexin-V apoptosis assays were performed to determine the cytotoxic effect and the induction of apoptosis. Then, the potential to inhibit cell migration was evaluated using a scratch test, and spheroid growth was measured. The results showed important cytotoxic effects of the drug combinations on both LOVO and LOVO\/DX cells. All tested substances caused an increase in the percentage of apoptotic cells in the LOVO cell line and necrotic cells in the LOVO\/DX cell subline. The strongest effect on the induction of cancer cell death was observed for the combination of irinotecan with celastrol (1.25 \u00b5M) or wogonin (50 \u00b5M) and for the combination of melatonin (2000 \u00b5M) with celastrol (1.25 \u00b5M) or wogonin (50 \u00b5M). Statistically significant improvements in the effect of combined therapy were found for the irinotecan (20 \u00b5M) and celastrol (1.25 \u00b5M) combination and irinotecan (20 \u00b5M) with wogonin (25 \u00b5M) in LOVO\/DX cells. Minor additive effects of combined therapy were observed in LOVO cells. Inhibition of cell migration was seen in LOVO cells for all tested compounds, while only irinotecan (20 \u00b5M) and celastrol (1.25 \u00b5M) were able to inhibit LOVO\/DX cell migration. Compared with single-drug therapy, a statistically significant inhibitory effect on cell migration was found for combinations of melatonin (2000 \u00b5M) with wogonin (25 \u00b5M) in LOVO\/DX cells and irinotecan (5 \u00b5M) or melatonin (2000 \u00b5M) with wogonin (25 \u00b5M) in LOVO cells. Our research shows that adding melatonin, wogonin, or celastrol to standard irinotecan therapy may potentiate the anti-cancer effects of irinotecan alone in colon cancer treatment. Celastrol seems to have the greatest supporting therapy effect, especially for the treatment of aggressive types of colon cancer, by targeting cancer stem-like cells.<\/jats:p>","DOI":"10.3390\/ijms24119544","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T03:59:35Z","timestamp":1685505575000},"page":"9544","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Combination of Irinotecan and Melatonin with the Natural Compounds Wogonin and Celastrol for Colon Cancer Treatment"],"prefix":"10.3390","volume":"24","author":[{"given":"Anna","family":"Radajewska","sequence":"first","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"},{"name":"Department of Medical Laboratory Diagnostics, Division of Clinical Chemistry and Laboratory Hematology, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8084-3686","authenticated-orcid":false,"given":"Helena","family":"Moreira","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"},{"name":"The Hubert Curien pluridisciplinary Institute, UMR 7178 Centre National de la Recherche Scientifique (CNRS), University of Strasbourg, 67081 Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorota","family":"B\u0119ben","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"Siwiela","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Szyjka","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"G\u0119bczak","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Nowak","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakub","family":"Fr\u0105szczak","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fathi","family":"Emhemmed","sequence":"additional","affiliation":[{"name":"The Hubert Curien pluridisciplinary Institute, UMR 7178 Centre National de la Recherche Scientifique (CNRS), University of Strasbourg, 67081 Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3463-1025","authenticated-orcid":false,"given":"Christian D.","family":"Muller","sequence":"additional","affiliation":[{"name":"The Hubert Curien pluridisciplinary Institute, UMR 7178 Centre National de la Recherche Scientifique (CNRS), University of Strasbourg, 67081 Illkirch, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Barg","sequence":"additional","affiliation":[{"name":"Department of Basic Medical Sciences, Wroclaw Medical University, 50-556 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","first-page":"89","article-title":"Epidemiology of colorectal cancer: Incidence, mortality, survival, and risk factors","volume":"14","author":"Rawla","year":"2019","journal-title":"Prz. Gastroenterol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Sawicki, T., Ruszkowska, M., Danielewicz, A., Nied\u017awiedzka, E., Ar\u0142ukowicz, T., and Przyby\u0142owicz, K.E. (2021). A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13.","DOI":"10.3390\/cancers13092025"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"808","DOI":"10.4251\/wjgo.v12.i8.808","article-title":"Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions","volume":"12","author":"Chakrabarti","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e5416923","DOI":"10.1155\/2018\/5416923","article-title":"Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment","volume":"2018","author":"Phi","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104398","DOI":"10.1016\/j.phrs.2019.104398","article-title":"Irinotecan: 25 years of cancer treatment","volume":"148","author":"Bailly","year":"2019","journal-title":"Pharmacol. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40262-018-0644-7","article-title":"Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics","volume":"57","author":"Goey","year":"2018","journal-title":"Clin. Pharmacokinet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/carcin\/bgi080","article-title":"Green tea intake, ACE gene polymorphism and breast cancer risk among Chinese women in Singapore","volume":"26","author":"Yuan","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/cbin.11543","article-title":"Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line","volume":"45","author":"Asadi","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2217\/nnm-2021-0334","article-title":"Anticancer evaluation of methotrexate and curcumin-coencapsulated niosomes against colorectal cancer cell lines","volume":"17","author":"Mousazadeh","year":"2022","journal-title":"Nanomedicine"},{"key":"ref_10","first-page":"799","article-title":"Plant derived substances with anti-cancer activity: From folklore to practice","volume":"6","author":"Efridlender","year":"2015","journal-title":"Front. Plant Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lfs.2019.05.009","article-title":"Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review","volume":"228","author":"Mortezaee","year":"2019","journal-title":"Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Talib, W.H. (2018). Melatonin and Cancer Hallmarks. Molecules, 23.","DOI":"10.3390\/molecules23030518"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"39896","DOI":"10.18632\/oncotarget.16379","article-title":"Melatonin for the prevention and treatment of cancer","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e12380","DOI":"10.1111\/jpi.12380","article-title":"Melatonin synergizes the chemotherapeutic effect of 5-fluorouracil in colon cancer by suppressing PI3K\/AKT and NF-\u03baB\/iNOS signaling pathways","volume":"62","author":"Gao","year":"2017","journal-title":"J. Pineal Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/jpi.12035","article-title":"Melatonin potentiates the antiproliferative and pro-apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways","volume":"54","author":"Wang","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_16","first-page":"e9935451","article-title":"The Therapeutic Potential of Wogonin Observed in Preclinical Studies","volume":"2021","author":"Salazar","year":"2021","journal-title":"Evid.-Based Complement. Altern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1080\/21655979.2021.2019173","article-title":"Effects of wogonin on the growth and metastasis of colon cancer through the Hippo signaling pathway","volume":"13","author":"You","year":"2022","journal-title":"Bioengineered"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1002\/ptr.7386","article-title":"Wogonin and its analogs for the prevention and treatment of cancer: A systematic review","volume":"36","author":"Banik","year":"2022","journal-title":"Phytother. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","article-title":"Celastrol in cancer therapy: Recent developments, challenges and prospects","volume":"521","author":"Lim","year":"2021","journal-title":"Cancer Lett."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/10715762.2019.1575512","article-title":"Celastrol suppresses nitric oxide synthases and the angiogenesis pathway in colorectal cancer","volume":"53","author":"Gao","year":"2019","journal-title":"Free Radic. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2147\/OTT.S187817","article-title":"Celastrol inhibits colorectal cancer through TGF-\u03b21\/Smad signaling","volume":"12","author":"Jiang","year":"2019","journal-title":"OncoTargets Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6793957","DOI":"10.1155\/2019\/6793957","article-title":"Prooxidative Activity of Celastrol Induces Apoptosis, DNA Damage, and Cell Cycle Arrest in Drug-Resistant Human Colon Cancer Cells","volume":"2019","author":"Moreira","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_23","unstructured":"(2023, February 27). PubChem, Irinotecan Hydrochloride, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/74990."},{"key":"ref_24","unstructured":"(2023, February 27). PubChem, Melatonin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/896."},{"key":"ref_25","unstructured":"(2023, February 27). Celastrol|C29H38O4\u2014PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/122724#section=Structures."},{"key":"ref_26","unstructured":"(2023, February 27). PubChem, Wogonin, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5281703."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1517\/14712598.2016.1108405","article-title":"Current and advancing treatments for metastatic colorectal cancer","volume":"16","author":"Grasselli","year":"2016","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/tpj.2010.10","article-title":"Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer","volume":"11","author":"Glimelius","year":"2011","journal-title":"Pharmacogenom. J."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Ma, S., Zhang, J., Yan, T., Miao, M., Cao, Y., Cao, Y., Zhang, L., and Li, L. (2023). Novel strategies to reverse chemoresistance in colorectal cancer. Cancer Med.","DOI":"10.1002\/cam4.5594"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.ejmech.2018.12.035","article-title":"Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment","volume":"163","author":"Zhuang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1038\/s41388-020-1341-1","article-title":"Gut microbiota modulation: A novel strategy for prevention and treatment of colorectal cancer","volume":"39","author":"Fong","year":"2020","journal-title":"Oncogene"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.3892\/or.2014.3042","article-title":"\u03b23GnT8 regulates the metastatic potential of colorectal carcinoma cells by altering the glycosylation of CD","volume":"31","author":"Ni","year":"2014","journal-title":"Oncol. Rep."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Moreira, H., Szyjka, A., Grzesik, J., Pelc, K., \u017buk, M., Kulma, A., Emhemmed, F., Muller, C.D., G\u0105siorowski, K., and Barg, E. (2022). Celastrol and Resveratrol Modulate SIRT Genes Expression and Exert Anticancer Activity in Colon Cancer Cells and Cancer Stem-like Cells. Cancers, 14.","DOI":"10.3390\/cancers14061372"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1158\/1055-9965.EPI-08-0637","article-title":"Urinary Melatonin Levels and Postmenopausal Breast Cancer Risk in the Nurses\u2019 Health Study Cohort","volume":"18","author":"Schernhammer","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e00396","DOI":"10.14309\/ctg.0000000000000396","article-title":"Use of Melatonin Is Associated with Lower Risk of Colorectal Cancer in Older Adults","volume":"12","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Talib, W.H., Alsayed, A.R., Abuawad, A., Daoud, S., and Mahmod, A.I. (2021). Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities. Molecules, 26.","DOI":"10.3390\/molecules26092506"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.tiv.2013.11.007","article-title":"The antioxidants, vitamin A and E but not vitamin C and melatonin enhance the proapoptotic effects of irinotecan in cancer cells in vitro","volume":"28","author":"Kontek","year":"2014","journal-title":"Toxicol. Vitr."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Wang, Q., Sun, Z., Du, L., Xu, C., Wang, Y., Yang, B., He, N., Wang, J., Ji, K., and Liu, Y. (2018). Melatonin Sensitizes Human Colorectal Cancer Cells to \u03b3-ray Ionizing Radiation In Vitro and In Vivo. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123974"},{"key":"ref_39","first-page":"364","article-title":"A four-component combination derived from Huang-Qin Decoction significantly enhances anticancer activity of irinotecan","volume":"19","author":"Xu","year":"2021","journal-title":"Chin. J. Nat. Med."},{"key":"ref_40","first-page":"467","article-title":"Effect of baicalein and wogonin on side population quantity in human breast and colon cancers","volume":"3","author":"Moreira","year":"2015","journal-title":"Bromat. Chem. Toksykol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.3892\/ijo.2013.1777","article-title":"Hydrophobic flavonoids from Scutellaria baicalensis induce colorectal cancer cell apoptosis through a mitochondrial-mediated pathway","volume":"42","author":"Wang","year":"2013","journal-title":"Int. J. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.3892\/ol.2017.6059","article-title":"Combination of wogonin and sorafenib effectively kills human hepatocellular carcinoma cells through apoptosis potentiation and autophagy inhibition","volume":"13","author":"Rong","year":"2017","journal-title":"Oncol. Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10565-010-9176-0","article-title":"Combined activity of oridonin and wogonin in advanced-stage ovarian cancer cells","volume":"27","author":"Chen","year":"2011","journal-title":"Cell Biol. Toxicol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s10495-016-1284-8","article-title":"Targeting Nrf2 with wogonin overcomes cisplatin resistance in head and neck cancer","volume":"21","author":"Kim","year":"2016","journal-title":"Apoptosis"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.3389\/fphar.2020.01152","article-title":"Wogonin Induces Apoptosis and Reverses Sunitinib Resistance of Renal Cell Carcinoma Cells via Inhibiting CDK4-RB Pathway","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00280-010-1396-8","article-title":"Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects","volume":"67","author":"Enomoto","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_47","first-page":"4068","article-title":"Celastrol Enhances the Anti-Liver Cancer Activity of Sorafenib","volume":"25","author":"Zhang","year":"2019","journal-title":"Experiment"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e5532269","DOI":"10.1155\/2021\/5532269","article-title":"The Synergistic Effects of Celastrol in combination with Tamoxifen on Apoptosis and Autophagy in MCF-7 Cells","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Immunol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Habra, K., Pearson, J.R.D., and McArdle, S.E.B. (FEBS Open Bio, 2022). Robust Formation of Optimal Single Spheroids towards Cost-Effective In-Vitro 3-Dimensional Tumor Models, FEBS Open Bio, in review.","DOI":"10.21203\/rs.3.rs-1695738\/v1"},{"key":"ref_50","unstructured":"(2021, December 20). Incucyte\u00ae Single Spheroid Assay, Sartorius Protocol. Available online: https:\/\/www.sartorius.com\/."},{"key":"ref_51","unstructured":"(2021, December 20). Incucyte\u00ae Scratch Wound Assay, Sartorius Protocol. Available online: https:\/\/www.sartorius.com\/."},{"key":"ref_52","first-page":"101423","article-title":"Comparison of in vitro scratch wound assay experimental procedures","volume":"33","author":"Radstake","year":"2023","journal-title":"Biochem. Biophys. Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9544\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:57Z","timestamp":1760125557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/11\/9544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["ijms24119544"],"URL":"https:\/\/doi.org\/10.3390\/ijms24119544","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}